Breaking News

WuXi Vaccines Launches Vaccines CDMO Site in China

Aims to add drug substance and drug product capacity, with services for diversified vaccines.

WuXi Vaccines, a contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing, launched its first standalone vaccines CDMO site in Suzhou, China. The opening will add drug substance and drug product capacity, with services for diversified vaccines from process development and drug product development to clinical-scale drug substance (DS) and small-to-medium sterile drug product (DP) manufacturing. Its DS production area includes tw...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters